The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize
Open accessAbstract
On the centenary of Paul Ehrlich’s Nobel Prize, this German researcher deserves to be remembered as a pioneer in a large number of scientific disciplines. As a result of his enthusiasm and scientific abilities, dedication, and contacts with other scientists of his time, he was able to make countless contributions in fields as diverse as histology, haematology, immunology, oncology, microbiology and pharmacology, among others. Although the Swedish award was meant to recognize the standardization of the manufacture of antidiphtheria serum, it was the discovery of arsphenamine (Salvarsan) for the treatment of syphilis which won him wider international acclaim. From a pharmacological perspective, Ehrlich’s outstanding contributions include dissemination of the ‘magic bullet’ concept for the synthesis of antibacterials, introduction of concepts such as chemoreceptor and chemotherapy, and linking the chemical structure of compounds to their pharmacological activity. These achievements took place within the framework he established for the transition from experimental pharmacology to therapeutic pharmacology. He introduced a modern research system based on the synthesis of multiple chemical structures for pharmacological screening in animal models of disease states. These contributions were undoubtedly decisive in propitiating the wider development of antibiotics decades later. For these reasons, it is fitting to mark the 100th anniversary of the Nobel Prize awarded to this great scientist by commemorating the importance of his contributions to the advance of pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sneader, W. (2005) · Cited by 302
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461471 · Cited by 256
Schwartz, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048021 · Cited by 221
Paul Ehrlich — in search of the magic bullet
Winau, F., Westphal, O., & Winau, R. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.003 · Cited by 164
A History of the Use of Arsenicals in Man
Jolliffe, D. (1993) · Journal of the Royal Society of Medicine · doi:10.1177/014107689308600515 · Cited by 118
Rubin, R. P. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.70102 · Cited by 113
Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells
Enrico Crivellato, B., Beltrami, C. A., Mallardi, F., & Ribatti, D. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04573.x · Cited by 110
Paul Ehrlich: founder of chemotherapy
Kaufmann, S. H. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2582 · Cited by 104
The contributions of Paul Ehrlich to infectious disease
Gensini, G. F., Conti, A. A., & Lippi, D. (2006) · Journal of Infection · doi:10.1016/j.jinf.2004.05.022 · Cited by 82
The concept of transmitter receptors: 100 years on
Bennett, M. R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00137-9 · Cited by 69
Cited by
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
Sulfur-Containing Agrochemicals
Devendar, P., & Yang, G.-F. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0169-9 · Cited by 481
Kaur, H., Mohanta, G. C., Gupta, V., Kukkar, D., & Tyagi, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.07.004 · Cited by 434
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000443526 · Cited by 409
Bacterial antimicrobial metal ion resistance
Hobman, J. L., & Crossman, L. C. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.023036-0 · Cited by 397
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 378
Al-Worafi, Y. M. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00008-x · Cited by 371
Emerging Role of Precision Medicine in Cardiovascular Disease
Leopold, J. A., & Loscalzo, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.310782 · Cited by 362
Engineered protein scaffolds as next-generation antibody therapeutics
Gebauer, M., & Skerra, A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.627 · Cited by 341
History of Antibiotics Research
Mohr, K. I. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_499 · Cited by 287
The development of drugs for treatment of sleeping sickness: a historical review
Steverding, D. (2010) · Parasites & Vectors · doi:10.1186/1756-3305-3-15 · Cited by 274
Animal Experiments in Biomedical Research: A Historical Perspective
Franco, N. (2013) · Animals · doi:10.3390/ani3010238 · Cited by 265
“In 1908, Ehrlich would also be awarded the Nobel Prize for contributions to immunology, and would yet again be nominated for his contributions to chemotherapy and the development of Salvasaran (an effective treatment against syphilis), in particular [132–135].”
BackgroundA Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Metadata
- Authors
- Bosch, F., & Rosich, L.
- Venue
- Pharmacology
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 82
- Issue
- 3
- Pages
- 171-179
- ISSN
- 0031-7012 (ISSN-L)
- 1423-0313
- OpenAlex
- W1994176596
- Cited by
- 292
- References
- 15
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.